THE Philippine National Volleyball Federation (PNVF) and Premier Volleyball League (PVL) is entertaining the possibility of allowing Alas Pilipinas women to joinTHE Philippine National Volleyball Federation (PNVF) and Premier Volleyball League (PVL) is entertaining the possibility of allowing Alas Pilipinas women to join

PNVF and PVL planning to allow Alas Pilipinas women to join professional league rookie draft

2026/02/24 18:51
2 min read
For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

THE Philippine National Volleyball Federation (PNVF) and Premier Volleyball League (PVL) is entertaining the possibility of allowing Alas Pilipinas women to join the pro league’s rookie draft later this year to allow it to have its own pool and not relying too much from the pros.

This will allow Alas coach Tai Bundit to select from the new batch of neophytes and form its own pool that would exclusively focus on national team duties for two years with their salaries being paid directly by the PNVF.

“Let’s say Alas picked 12 out of the 40 draft applicants, PVL teams can start drafting with that 28 remaining players with the 12 chosen being now members of the national team and cannot be signed by any club teams,” said PNVF chief Tonyboy Liao during Tuesday’s media briefer at their BGC office in Taguig.

Also gracing the event were PNVF Vice-President Yul Benosa, Secretary-General Otie Camangian and board members Fr. Vic Calvo, OP, and Sherwin Maganda.

Mr. Liao stressed he has talked to the more than majority teams in the PVL and should get the nod from the rest.

“I’ve already talked to six of the 10 PVL teams with the other four I have yet to talk to. But I think they’ll follow for the good of the PVL and the national team,” he said.

If it ends up given the green light, the current Alas pool will play its last tournaments in the AVC Women’s Cup set June 6 to 14 in Candon, Ilocos Sur and the Southeast Asian V.League, which has no specific date and venue yet.

“This will be the last time the PVL players will play for the Philippine team, unless of course PVL players who didn’t renew decide to suit up for Alas,” said Mr. Liao. — Joey Villar

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09